Filing Flows › Teva Pharmaceutical Industries (TEVA) › Recalls, complaints & regulation
Teva Pharmaceutical Industries (TEVA): recalls, EPA violations and clinical trials
Teva Pharmaceutical Industries (TEVA) beyond its filings: 18 recalls in the last 12 months (62 in five years, 2 Class I); 3 EPA-regulated facilities in violation, no penalties in five years; 10 active clinical trials.
Latest recalls
- 2026-10-21 · FDA drug · Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 009
- 2026-09-09 · FDA drug · traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pha
- 2026-05-13 · FDA drug · Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled sy
- 2026-04-29 · FDA drug · Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, N
- 2026-04-15 · FDA drug · Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., S
- 2026-04-15 · FDA drug · Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., S
- 2026-04-15 · FDA drug · Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., S
- 2026-04-15 · FDA drug · Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| TEVA PARENTERAL MEDICINES, INC. | Irvine, CA | Violation | — |
| TEVA PHARMACEUTICALS USA INC | Mexico, MO | Significant Violation | — |
| TEVA PHARMACEUTICALS USA INC | Fairfield Twp, NJ | Violation Identified | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Teva Pharmaceutical Industries' latest quarter
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Questions
Has Teva Pharmaceutical Industries had any recalls?
62 recalls on file over five years from the FDA, CPSC and NHTSA; 18 in the last 12 months.
Has Teva Pharmaceutical Industries been fined by the EPA?
The 18 EPA-regulated facilities on file under its name drew no penalties in five years; 3 are in violation now.
How many clinical trials does Teva Pharmaceutical Industries have?
10 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.